Par Pharmaceutical logo — company profile

Par Pharmaceutical

Founded 1978 United States Chestnut Ridge, United States 1453 employees Health Care, Manufacturing +1

General Information

Company Name Par Pharmaceutical
Founded Year 1978
Location United States Chestnut Ridge, United States +4
Employees 1453
Industries Health Care, Manufacturing, Pharmaceutical
Social

Get notified when Par Pharmaceutical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Par Pharmaceutical

Par Pharmaceutical is a leading player in the generics industry, based in Chestnut Ridge, New York. Since its establishment in 1978, the company has been dedicated to developing, manufacturing, and marketing high-quality, cost-effective generic pharmaceutical and branded injectable products to enhance patient quality of life. With a focus on sterile injectables, alternative dosage forms, and other differentiated products, Par Pharmaceutical is at the forefront of innovation in the US generics market. Its commitment to research and development is evident through a robust pipeline of potential products. As an operating company of Endo International plc, a prominent generics and specialty branded pharmaceutical company, Par Pharmaceutical is dedicated to delivering quality medicines, underscoring excellence in development, manufacturing, and commercialization. The company's efforts align with the Health Care, Manufacturing, and Pharmaceutical sectors. Although specific investment details are not available, given its strong market presence, innovative product portfolio, and association with Endo International plc, Par Pharmaceutical presents potential opportunities for venture capital firms seeking to invest in the healthcare and pharmaceutical sectors.

Taxonomy: pharmaceutical company, generic pharmaceuticals, injectable products, R&D pipeline, sterile injectables, cost-effective products, innovative medicines, patient quality of life, Endo International plc, medicine manufacturing, specialty care pharmaceuticals, high-quality generics, drug manufacturing

No funding data available for Par Pharmaceutical yet.

Get notified when Par Pharmaceutical raises funding

Par Pharmaceutical Alternatives & Competitors

Par Pharmaceutical vs

Pharmaceutical company | Development, manufacturing and marketing of innovative prescription, generi...

502 employees
Health Care, Manufacturing
Par Pharmaceutical vs

Health is wealth with Livealth

25 employees
Biopharma, Pharmaceutical
Par Pharmaceutical vs

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused...

Post Ipo Equity
132 employees
Biotechnology, Health Care

FAQ About Par Pharmaceutical

Par Pharmaceutical: High-Quality, Cost-Effective Generic Products Par Pharmaceutical, headquartered in Chestnut Ridge, New York, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. P...
Par Pharmaceutical was founded in 1978.
Par Pharmaceutical is headquartered in Chestnut Ridge, United States.
Par Pharmaceutical operates in the following industries: Health Care, Manufacturing, Pharmaceutical.
Par Pharmaceutical has approximately 1453 employees.
Top alternatives and competitors to Par Pharmaceutical include Dexcel Pharma, Livealth Biopharma Pvt Ltd, Paladin Labs, Delorbis Pharmaceuticals Ltd, CCL Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Par Pharmaceutical and Dexcel Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Par Pharmaceutical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy